[Translation] A multicenter, randomized, double-blind, placebo-controlled Phase II clinical trial to evaluate the safety, tolerability and efficacy of RAY1225 injection in patients with type 2 diabetes
主要目的:
评价RAY1225注射液在2型糖尿病患者的耐受性;
通过分析糖化血红蛋白的变化,评价RAY1225注射液治疗2型糖尿病患者的有效性。
次要目的:
通过分析其他疗效指标的变化,评价RAY1225注射液治疗2型糖尿病患者的有效性;
评价RAY1225注射液在2型糖尿病患者的安全性;
评价RAY1225注射液在2型糖尿病患者的药代动力学特征。
[Translation] Primary purpose:
To evaluate the tolerability of RAY1225 injection in patients with type 2 diabetes;
To evaluate the effectiveness of RAY1225 injection in the treatment of patients with type 2 diabetes by analyzing the changes in glycosylated hemoglobin.
Secondary purpose:
To evaluate the effectiveness of RAY1225 injection in the treatment of patients with type 2 diabetes by analyzing the changes in other efficacy indicators;
To evaluate the safety of RAY1225 injection in patients with type 2 diabetes;
To evaluate the pharmacokinetic characteristics of RAY1225 injection in patients with type 2 diabetes.